Yüklüyor......
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Lung cancer is the leading cause of cancer death worldwide with low response rates to conventional chemotherapy. New promising therapies have emerged based on programmed cell death protein 1 (PD-1) immunity checkpoint inhibitors (ICI), including anti-PD-1, such as nivolumab and pembrolizumab, or pro...
Kaydedildi:
| Yayımlandı: | J Thorac Dis |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353738/ https://ncbi.nlm.nih.gov/pubmed/30775032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|